Imperial College Enterprise Funds

An early-stage investment fund backing technology spun out of Imperial College

Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Fund at a glance

Type of Fund
EIS Fund
Sector
Spinouts from Imperial College London
Investment stage
Seed-Series A
Portfolio size
5+ individual companies
Close date
This fund is now closed
Target deployment
12-18 months from initial subscription
Min investment
£25,000

Unlocking innovation, maximising tax benefits.

Investment Strategy

The Imperial College Enterprise Funds, in collaboration with Imperial College Enterprise, provide funding and support to companies founded on Imperial College’s research, helping transform these new scientific discoveries into tomorrow’s solutions.

Imperial College Enterprise is the college’s dedicated technology commercialisation and entrepreneurial support team, which offers a range of services, insights, expertise, networks and programmes to help entrepreneurs and academics develop their innovation ideas into commercial successes.

Portfolio Examples

Koalaa

Koalaa is developing the next generation of prosthetics and orthotics for people with upper limb differences. Koalaa has designed a range of comfortable, affordable and functional prosthetics with modular tools that clip into the sleeve to be used for specific tasks.
HealthTech Digital Health MedTech

Koalaa

Koalaa is developing the next generation of prosthetics and orthotics for people with upper limb differences. Koalaa has designed a range of comfortable, affordable and functional prosthetics with modular tools that clip into the sleeve to be used for specific tasks.
Sector
Digital Health, MedTech
Institution
Imperial College
Website
www.yourkoalaa.com

MintNeuro

MintNeuro is at the dynamic intersection of neurotechnology and semiconductors, pioneering efficient, scalable implantable devices for neurological care.
HealthTech Digital Health MedTech

MintNeuro

Mint Neurotechnologies Ltd (MintNeuro) is an innovative startup at the dynamic intersection of neurotechnology and semiconductors. MintNeuro is pioneering integrated circuit solutions for implantable medical devices targeting the management and treatment of neurological conditions. MintNeuro’s goal is to deliver scalable, less invasive, and highly efficient devices that transform neurological care.
Sector
Digital Health, MedTech
Institution
Imperial College
Website
mintneuro.com

GripAble

GripAble is developing an ecosystem of sensor-based devices and a software/data platform to replicate hospital rehabilitation therapy for in-home settings and hence to deliver improved clinical outcomes.  
HealthTech Digital Health MedTech

GripAble

GripAble is developing an ecosystem of sensor-based devices and a software/data platform to replicate hospital rehabilitation therapy for in-home settings and hence to deliver improved clinical outcomes.
Sector
Digital Health, MedTech
Institution
Imperial College
Website
gripable.co

EIS-backed ventures reshaping tomorrow

EIS tax reliefs available

Investors will receive individual EIS3 certificates allowing them to claim tax relief.

Taken together, for an additional rate taxpayer, these reliefs can reduce your net exposure so that, in some cases, you may risk as little as 38.5p for every £1 invested.

Please note: Investments must be held for 3 years to achieve all 5 tax reliefs. Tax reliefs are dependent upon investor’s circumstances. The investments described in this website will place your capital at risk. We strongly suggest that you seek specialist tax advice; Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Tax benefits below are as at November 2025. Loss Relief reduces the impact of a loss but does not eliminate it entirely.

Income Tax Relief

Available in the year of investment or carried back to previous year, provided investments are held for three years.
0 %

CGT Disposal Relief

Tax free capital gains on the investments, provided they are held for three years.

Capital Gains Tax Deferral

On gains made in prior three years or for one year following investments.

IHT Free

Provided investments are held for two years and at the time of death. A proposed limit of £1m is due to come into effect from 6th April 2026.

Loss Relief

Optional to claim losses against capital gains or income. This is based on an additional rate taxpayer.
Up to 0 %

Guide to EIS

For more information on EIS tax reliefs, visit our EIS Knowledge Hub. There you will find a range of educational materials, including guides and articles designed to help you understand the benefits of the scheme.

Learn more

Looking to invest?

If you’re interested in exploring investment opportunities with Parkwalk, please fill out the form or email us at sales@parkwalkadvisors.com.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Role (select one)
Select the funds you are interested in (select multiple)
Consent

Downloads

Contact us

For more on Parkwalk’s performance, please contact Susie and Harriet at sales@parkwalkadvisors.com.

Susie Harris

Director of Business Development

Susie is responsible for the overall fundraising strategy at Parkwalk, as well as managing strategic partnerships. She spends much of her time presenting Parkwalk’s funds to investors and wealth managers.

Harriet Doherty

Director of Sales and Marketing

Harriet is responsible for the overall marcomms strategy, as well as fundraising for Parkwalk’s EIS Funds – regularly presenting to investors, private clients and wealth managers. Harriet also manages some of the firm’s key strategic IFA relationships.

Funds

Learn about the full range of Parkwalk funds. Discover our flagship and university funds, understand the EIS tax incentives, and find out how to invest.
Explore Funds

The investments described in this website will place your capital at risk. Past performance may not be repeated and is not indicative of future results. Tax reliefs are dependent on investors’ individual circumstance and are subject to change. An investment in a fund managed by Parkwalk must be made only on the basis of the fund’s Information Memorandum and Key Information Document. Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such.

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.